Pro Medicus Limited

$ 172.80 3.10 %

Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.

CEO: Sam Aaron Hupert - https://www.promed.com.au

Price objectif

-

Recommandation

-

DCF

$ 95.97

Loading data...

PME.AX vs S&P500

Loading data...

No data available.

Quick ratio

6.22

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

76.80

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.25

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

72.67 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

25.88 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

7.01

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.01

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.30

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

24.49 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
4 indicates moderate financial health
Altman score
79.06 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
2.41 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.01 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.